Table 1 Baseline demographics and clinical characteristics of the ITT population
Characteristic | Cisplatin + gemcitabine + axitinib (n = 38) |
|---|---|
Age, years | |
Mean (SD) | 60.5 (7.1) |
Median (range) | 59.5 (47–73) |
Gender | |
Male | 34 (89.5) |
Female | 4 (10.5) |
Race | |
White | 37 (97.4) |
Black | 1 (2.6) |
Smoking status | |
Smoker | 33 (86.8) |
Non-smoker | 5 (13.2) |
Tumour histology | |
Squamous cell carcinoma | 38 (100) |
Disease stage | |
IIIB | 5 (13.2) |
IV | 33 (86.8) |
ECOG performance status | |
0 | 12 (31.6) |
1 | 26 (68.4) |
Prior surgery | 17 (44.7) |
Bronchoscopy | 11 (28.9) |
Lymph node/pleural biopsy | 6 (15.8) |
Lobectomy | 2 (5.2) |
Thoracic wall resection | 1 (2.6) |